Best Buy Free cash flow increased by 92.2% to $1.10B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 18.8%, from $1.36B to $1.10B. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$56.00M | $597.00M | $0.00 | $2.00B | -$1.60B | $1.70B | -$535.00M | $321.00M | -$108.00M | $997.00M | $4.00M | $478.00M | $1.36B | -$132.00M | $574.00M | $1.10B |
| QoQ Change | — | >999% | -100.0% | — | -179.9% | +206.2% | -131.5% | +160.0% | -133.6% | >999% | -99.6% | >999% | +184.3% | -109.7% | +534.8% | +92.2% |
| YoY Change | — | — | — | — | <-999% | -15.2% | +66.5% | — | — | -41.3% | +100.7% | +48.9% | +36.3% | <-999% | +20.1% | -18.8% |